These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


89 related items for PubMed ID: 6450829

  • 1. [Studies on beta-lactam antibiotics for medicinal purpose. XI. Studies on the metabolism of sodium 7-(D(-)-alpha-(4-ethyl-2,3-dioxo-1-piperazinecarboxamido)-alpha-(4-hydroxyphenyl)acetamido)-3-((1-methyl-1H-tetrazole-5-yl)thiomethyl)-3-cephem-4-carboxylate (T-1551) (author's transl)].
    Saikawa I, Nakashima Y, Sakai H, Momonoi K, Ikegami T, Minami H, Hayakawa H, Ochiai H, Todo Y.
    Yakugaku Zasshi; 1980 Jun; 100(6):625-40. PubMed ID: 6450829
    [No Abstract] [Full Text] [Related]

  • 2. [Studies on beta-lactam antibiotics for medicinal purpose. X. Stability and degradation pattern of sodium 7-[D(--)-alpha-(4-ethyl-2,3-dioxo-1-piperazinecarboxamido)-alpha-(4-hydroxyphenyl)acetamido]-3-[(1-methyl-1H-tetrazol-5-yl)thiomethyl]-3-cephem-4-carboxylate (T-1551) in aqueous solution (author's transl)].
    Saikawa I, Momonoi K, Sakai H, Takashita Y, Ohashi T, Minami H, Yamamoto Y, Fukuoka Y.
    Yakugaku Zasshi; 1979 Dec; 99(12):1207-18. PubMed ID: 544761
    [No Abstract] [Full Text] [Related]

  • 3. [Studies on the absorption distribution and excretion of 14C-labelled sodium 7-[D(-)-alpha-(4-ethyl-2,3-dioxo-1-piperazine-carboxamido)-alpha-(4-hydroxyphenyl l) acetamido]-3-[(1-methyl-1H-tetrazol-5-yl) thiomethyl]-3-cephem-4-carboxylate (14C-cefoperazone) in rats and mice].
    Saikawa I, Takai A, Nakashima Y, Ikegami T, Hayakawa H, Takagi T, Yamauchi H.
    Jpn J Antibiot; 1980 Oct; 33(10):1084-96. PubMed ID: 6451722
    [No Abstract] [Full Text] [Related]

  • 4. [Pharmacological study of beta-lactam antibiotics (15). Metabolism of sodium 7 beta-[(2R,3S)-2-(4-ethyl-2,3-dioxo-1-piperazinecarboxamido)-3- hydroxybutanamido]-7 alpha-methoxy-3- [1-methyl-1H-tetrazol-5-yl) thiomethyl]-3-cephem-4-carboxylate (T-1982)].
    Saikawa I, Nakashima Y, Tai M, Sakai H, Takakura I, Ikegami T, Hayakawa H, Shugimoto Y, Yamafuji T, Miyaura T.
    Yakugaku Zasshi; 1983 Apr; 103(4):414-25. PubMed ID: 6415264
    [No Abstract] [Full Text] [Related]

  • 5. [The autoradiographic studies on the distribution of 14C-labelled sodium 7-[D(-)-alpha-(4-ethyl-2, 3-dioxo-1-piperazinecarboxamido)-alpha-(4-hydroxyphenyl)-acetamido]-3-[(1-methyl -1 H-tetrazol-5-yl) thiomethyl]-3-cephem-4-carboxylate (14C-cefoperazone) in rats and mice].
    Saikawa I, Takai A, Nakashima Y, Ikegami T, Hayakawa H, Takagi T, Yamauchi H.
    Jpn J Antibiot; 1980 Oct; 33(10):1097-103. PubMed ID: 6451723
    [Abstract] [Full Text] [Related]

  • 6. [Studies on beta-lactam antibiotics for medicinal purposes. XXI. Studies on the metabolism of pivaloyloxymethyl (6R,7R)-7-[(Z)-2-(2-aminothiazol-4-yl)-2-methoxyiminoacetamido]- 3-[(5-methyl-2H-tetrazol-2-yl)methyl]-3-cephem-4-carboxylate (T-2588) (1)].
    Saikawa I, Tai M, Sugimoto Y, Imaizumi H, Takeda K, Sadaki H.
    Yakugaku Zasshi; 1986 Jun; 106(6):466-77. PubMed ID: 3761157
    [No Abstract] [Full Text] [Related]

  • 7. [Studies on absorption, distribution and excretion of 14C labelled sodium 7 beta-[(2R, 3S)-2-(4-ethyl-2,3-dioxo-1-piperazinecarboxamido)-3-hydroxybutanamido]-7-methoxy-3-[(1-methyl-1H-tetrazol-5-YL)thiomethyl]-3-cephem-4-carboxylate (14C-T-1982) in mice and rats].
    Saikawa I, Takai A, Nakashima Y, Ikegami T, Hayakawa H, Noguchi M, Yamauchi H, Shimizu H.
    Jpn J Antibiot; 1982 Sep; 35(9):2163-73. PubMed ID: 7143717
    [Abstract] [Full Text] [Related]

  • 8. [Studies on beta-lactam antibiotics for medicinal purpose. XVII. Synthesis and structure-activity relationships of 7 beta-[D(-)-alpha-amino-alpha-(4-hydroxyphenyl)acetamido]-3-substituted methyl-3-cephem-4-carboxylic acids].
    Sadaki H, Imaizumi H, Inaba T, Hirakawa T, Murotani Y, Watanabe Y, Minami S, Saikawa I.
    Yakugaku Zasshi; 1986 Feb; 106(2):123-8. PubMed ID: 3712237
    [No Abstract] [Full Text] [Related]

  • 9. [Studies on beta-lactam antibiotics for medicinal purpose. XIV. Stability and degradation pattern of sodium 7 beta-[(2R, 3S)-2-(4-ethyl-2, 3-dioxo-1-piperazinecarboxamido)-3-hydroxybutanamido]-7 alpha-methoxy-3-[(1-methyl-1H-tetrazol-5-yl)thiomethyl]-3-cephem-4- carboxylate (T-1982) in aqueous solution].
    Takano S, Tai M, Sakai H, Takakura I, Ochiai H, Sugimoto Y, Fukuoka Y, Saikawa I.
    Yakugaku Zasshi; 1983 Jan; 103(1):62-72. PubMed ID: 6864450
    [No Abstract] [Full Text] [Related]

  • 10. [Studies on beta-lactam antibiotics for medicinal purpose. VI. Studies on the metabolism of 6-[D(--)-alpha-(4-ethyl-2,3-dioxo-1-piperazinecarboxamido)-phenylacetamido]penicillanic acid (T-1220) (author's transl)].
    Saikawa I, Takai A, Nakashima Y, Yoshida C, Yasuda T.
    Yakugaku Zasshi; 1977 Oct; 97(10):1071-81. PubMed ID: 412944
    [No Abstract] [Full Text] [Related]

  • 11. [Studies on beta-lactam antibiotics for medicinal purposes. XXII. Studies on the metabolism of pivaloyloxymethyl (6R,7R)-7-[(Z)-2-(2-aminothiazol-4-yl)-2-methoxyiminoacetamido]- 3-[(5-methyl-2H-tetrazol-2-yl)methyl]-3-cephem-4-carboxylate (T-2588) (2)].
    Saikawa I, Nakajima Y, Tai M, Sakai H, Demachi K, Kajita T, Hayakawa H, Onoda M, Fukuda H, Sadaki H.
    Yakugaku Zasshi; 1986 Jun; 106(6):478-90. PubMed ID: 3761158
    [No Abstract] [Full Text] [Related]

  • 12. Cefoperazone: absorption, excretion, distribution, and metabolism.
    Shimizu K.
    Clin Ther; 1980 Jun; 3(Spec Issue):60-79. PubMed ID: 6446400
    [No Abstract] [Full Text] [Related]

  • 13. [The whole body autoradiographic studies on the distribution of 14C-labelled sodium 7 beta-[(2R, 3S)-2-(4-ethyl-2, 3-dioxo-1-piperazine-carboxamido)-3-hydroxybutanamido]-7 alpha-methoxy-3-[(1-methyl-1H-tetrazol-5-yl)thiomethyl]-3-cephem-4-carboxylate (14C-T-1982) in mice].
    Saikawa I, Takai A, Nakashima Y, Ikegami T, Hayakawa H, Noguchi M, Yamauchi H, Shimizu H.
    Jpn J Antibiot; 1982 Sep; 35(9):2159-62. PubMed ID: 7143716
    [Abstract] [Full Text] [Related]

  • 14. [Studies on beta-lactam antibiotics for medicinal purpose. XVIII. Synthesis and structure-activity relationships of 7 beta-[(Z)-2-(2-aminothiazol-4-yl)-2-methoxyiminoacetamido]-3- substitut ed methyl-3-cephem-4-carboxylic acid derivatives].
    Sadaki H, Imaizumi H, Inaba T, Hirakawa T, Murotani Y, Watanabe Y, Minami S, Saikawa I.
    Yakugaku Zasshi; 1986 Feb; 106(2):129-46. PubMed ID: 3712238
    [No Abstract] [Full Text] [Related]

  • 15. [Studies on beta-lactam antibiotics for medicinal purpose. XIII. Synthesis and structure-activity relationships of 7 beta-[alpha-(4-alkyl-2,3-dioxo-1-piperazinecarboxamido)-alpha-substituted acetamido]-7 alpha-methoxycephalosporanic acids].
    Takano S, Takakura I, Ochiai H, Momonoi K, Tanaka K, Todo Y, Yasuda T, Tai M, Fukuoka Y, Taki H, Saikawa I.
    Yakugaku Zasshi; 1982 Jul; 102(7):629-45. PubMed ID: 7153852
    [No Abstract] [Full Text] [Related]

  • 16. Absorption, distribution and excretion of SCE-963, a new broad-spectrum cephalosporin, in mice, rats, rabbits and dogs.
    Tsuchiya K, Kondo M, Kita Y, Noji Y, Takeuchi M, Fugono T.
    J Antibiot (Tokyo); 1978 Dec; 31(12):1272-82. PubMed ID: 738967
    [Abstract] [Full Text] [Related]

  • 17. [Studies on beta-lactam antibiotics for medicinal purpose. III. Structure-activity relationship of 6-[D(-)-alpha-(4-alkyl-2,3-dioxo-1-piperazinecarbox-amido)phenylacetamido]penicillanic acids (author's transl)].
    Saikawa I, Yasuda T, Taki H, Tai M, Watanabe Y.
    Yakugaku Zasshi; 1977 Sep; 97(9):987-94. PubMed ID: 200728
    [No Abstract] [Full Text] [Related]

  • 18. [Studies on beta-lactam antibiotics for medicinal purpose. IV. Stability of 6-[D(-)-alpha-(4-ethyl-2,3-dioxo-1-piperazinecarboxamido)phenylacetamido)penicillanic acid (T-1220) in aqueous solution and body fluid (author's transl)].
    Saikawa I, Takano S, Yoshida C, Saito E, Yasuda T.
    Yakugaku Zasshi; 1977 Sep; 97(9):995-1001. PubMed ID: 21947
    [No Abstract] [Full Text] [Related]

  • 19. Absorption, distribution and excretion of cefmenoxime (SCE-1365), a novel broad-spectrum cephalosporin, in mice, rats, rabbits and dogs.
    Tsuchiya K, Kita Y, Yamazaki I, Kondo M, Noji Y, Fugono T.
    J Antibiot (Tokyo); 1980 Dec; 33(12):1532-44. PubMed ID: 6941956
    [Abstract] [Full Text] [Related]

  • 20. [Studies on beta-lactam antibiotics for medicinal purpose. XIX. Synthesis and structure-activity relationships of 7 beta-acylamido-3-[(5-methyl-2H-tetrazol-2-yl)methyl]-3-cep hem-4-carbox ylic acid, 7 beta-acylamido-3-[(5-chloro-1,2,4-triazol-1-yl)methyl]-3-c ephem-4-carb oxylic acid and their derivatives].
    Sadaki H, Imaizumi H, Inaba T, Hirakawa T, Murotani Y, Watanabe Y, Minami S, Saikawa I.
    Yakugaku Zasshi; 1986 Feb; 106(2):147-53. PubMed ID: 3712239
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.